Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F23092)
Formulation Name
Brexanolone 100 mg/20 ml Injection
Company
Sage Therapeutics
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Allopregnanolone
DMNLHAC
Depression
6A70-6A7Z
approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Betadex sulfobutyl ether sodium
E00589
66577045
Solubilizing agent
Citric acid monohydrate
E00271
22230
Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Hydrochloric acid
E00015
313
Acidulant
Sodium citrate dihydrate
E00369
71474
Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Sodium hydroxide
E00234
14798
Alkalizing agent
Water
E00035
962
Solvent
--------------------